New peptide research blend shows promise as a game-changer in the fitness space BURTON, MI, UNITED STATES, January 19, ...

Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue? Over the past ...

A South Korean life sciences company plans to open a genetic testing lab in North Austin, a move that could create up to 200 jobs. Last week, the Austin City Council approved a $200,000 economic ...

The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

COLUMBUS, Ohio (WCMH) — Girls at Hilltonia Middle School got a hands-on experience in health care science Tuesday. After ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2025 Earnings Call Transcript February 10, 2026 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $1.86, expectations were $1.81. Rebecca: ...

They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...

Dr. Cindi Love, Executive Director of Out for Undergrad, emphasized the significance of Valladares’ appointment: ...

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

Roivant saw its share prices jump by 19.4 percent week-on-week, hitting a new all-time high, as investors snapped up shares ...

Q4 2025 Earnings Call February 10, 2026 4:30 PM ESTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...